Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 299

1.

Simultaneous quantification of dopamine, serotonin, their metabolites and amino acids by LC-MS/MS in mouse brain following repetitive transcranial magnetic stimulation.

Poh EZ, Hahne D, Moretti J, Harvey AR, Clarke MW, Rodger J.

Neurochem Int. 2019 Sep 10;131:104546. doi: 10.1016/j.neuint.2019.104546. [Epub ahead of print]

PMID:
31518601
2.

Detection of a vita-PAMP STINGs cells into reticulophagy.

Moretti J, Blander JM.

Autophagy. 2018;14(6):1102-1104. doi: 10.1080/15548627.2018.1441471. Epub 2018 May 21.

3.

Measuring Innate Immune Responses to Bacterial Viability.

Moretti J, Vabret N, Blander JM.

Methods Mol Biol. 2018;1714:167-190. doi: 10.1007/978-1-4939-7519-8_11.

PMID:
29177862
4.

STING Senses Microbial Viability to Orchestrate Stress-Mediated Autophagy of the Endoplasmic Reticulum.

Moretti J, Roy S, Bozec D, Martinez J, Chapman JR, Ueberheide B, Lamming DW, Chen ZJ, Horng T, Yeretssian G, Green DR, Blander JM.

Cell. 2017 Nov 2;171(4):809-823.e13. doi: 10.1016/j.cell.2017.09.034. Epub 2017 Oct 19.

5.

Analysis of in vitro evolution reveals the underlying distribution of catalytic activity among random sequences.

Pressman A, Moretti JE, Campbell GW, Müller UF, Chen IA.

Nucleic Acids Res. 2017 Oct 13;45(18):10922. doi: 10.1093/nar/gkx816. No abstract available.

6.

Analysis of in vitro evolution reveals the underlying distribution of catalytic activity among random sequences.

Pressman A, Moretti JE, Campbell GW, Müller UF, Chen IA.

Nucleic Acids Res. 2017 Aug 21;45(14):8167-8179. doi: 10.1093/nar/gkx540.

7.

Cell-autonomous stress responses in innate immunity.

Moretti J, Blander JM.

J Leukoc Biol. 2017 Jan;101(1):77-86. doi: 10.1189/jlb.2MR0416-201R. Epub 2016 Oct 12. Review.

8.

Correction: TspanC8 tetraspanins regulate ADAM10/Kuzbanian trafficking and promote Notch activation in flies and mammals.

Dornier E, Coumailleau F, Ottavi JF, Moretti J, Boucheix C, Mauduit P, Schweisguth F, Rubinstein E.

J Cell Biol. 2016 May 23;213(4):495-6. doi: 10.1083/jcb.20120113304262016c. Epub 2016 May 16. No abstract available.

9.

Contribution of Orexin to the Neurogenic Hypertension in BPH/2J Mice.

Jackson KL, Dampney BW, Moretti JL, Stevenson ER, Davern PJ, Carrive P, Head GA.

Hypertension. 2016 May;67(5):959-69. doi: 10.1161/HYPERTENSIONAHA.115.07053. Epub 2016 Mar 14.

PMID:
26975709
10.

Comparison of sympathetic nerve activity normalization procedures in conscious rabbits.

Burke SL, Lim K, Moretti JL, Head GA.

Am J Physiol Heart Circ Physiol. 2016 May 1;310(9):H1222-32. doi: 10.1152/ajpheart.00866.2015. Epub 2016 Feb 26.

11.
12.

Chlorine-Free Red-Burning Pyrotechnics.

Sabatini JJ, Koch EC, Poret JC, Moretti JD, Harbol SM.

Angew Chem Int Ed Engl. 2015 Sep 7;54(37):10968-70. doi: 10.1002/anie.201505829.

PMID:
26333055
13.

High-performing red-light-emitting pyrotechnic illuminants through the use of perchlorate-free materials.

Moretti JD, Sabatini JJ, Poret JC.

Chemistry. 2014 Jul 7;20(28):8800-4. doi: 10.1002/chem.201402654. Epub 2014 Jun 17.

PMID:
24939042
14.

Insights into phagocytosis-coupled activation of pattern recognition receptors and inflammasomes.

Moretti J, Blander JM.

Curr Opin Immunol. 2014 Feb;26:100-10. doi: 10.1016/j.coi.2013.11.003. Epub 2013 Dec 5. Review.

15.

A ribozyme that triphosphorylates RNA 5'-hydroxyl groups.

Moretti JE, Müller UF.

Nucleic Acids Res. 2014 Apr;42(7):4767-78. doi: 10.1093/nar/gkt1405. Epub 2014 Jan 21.

16.

A glycosphingolipid binding domain controls trafficking and activity of the mammalian notch ligand delta-like 1.

Heuss SF, Tarantino N, Fantini J, Ndiaye-Lobry D, Moretti J, Israël A, Logeat F.

PLoS One. 2013 Sep 12;8(9):e74392. doi: 10.1371/journal.pone.0074392. eCollection 2013.

17.

High-nitrogen-based pyrotechnics: perchlorate-free red- and green-light illuminants based on 5-aminotetrazole.

Sabatini JJ, Moretti JD.

Chemistry. 2013 Sep 16;19(38):12839-45. doi: 10.1002/chem.201300779. Epub 2013 Aug 16.

PMID:
23950104
18.

Ubiquitinations in the notch signaling pathway.

Moretti J, Brou C.

Int J Mol Sci. 2013 Mar 19;14(3):6359-81. doi: 10.3390/ijms14036359.

19.

TspanC8 tetraspanins regulate ADAM10/Kuzbanian trafficking and promote Notch activation in flies and mammals.

Dornier E, Coumailleau F, Ottavi JF, Moretti J, Boucheix C, Mauduit P, Schweisguth F, Rubinstein E.

J Cell Biol. 2012 Oct 29;199(3):481-96. doi: 10.1083/jcb.201201133. Epub 2012 Oct 22. Erratum in: J Cell Biol. 2016 May 23;213(4):495-6.

20.

The ubiquitin-specific protease 12 (USP12) is a negative regulator of notch signaling acting on notch receptor trafficking toward degradation.

Moretti J, Chastagner P, Liang CC, Cohn MA, Israël A, Brou C.

J Biol Chem. 2012 Aug 24;287(35):29429-41. doi: 10.1074/jbc.M112.366807. Epub 2012 Jul 9.

21.

Periodate salts as pyrotechnic oxidizers: development of barium- and perchlorate-free incendiary formulations.

Moretti JD, Sabatini JJ, Chen G.

Angew Chem Int Ed Engl. 2012 Jul 9;51(28):6981-3. doi: 10.1002/anie.201202589. Epub 2012 May 25.

PMID:
22639415
22.

Minimal fluorous tagging strategy that enables the synthesis of the complete stereoisomer library of SCH725674 macrolactones.

Moretti JD, Wang X, Curran DP.

J Am Chem Soc. 2012 May 9;134(18):7963-70. doi: 10.1021/ja302260d. Epub 2012 May 1.

23.

Renal sympathetic activation from long-term low-dose angiotensin II infusion in rabbits.

Moretti JL, Burke SL, Davern PJ, Evans RG, Lambert GW, Head GA.

J Hypertens. 2012 Mar;30(3):551-60. doi: 10.1097/HJH.0b013e328350133a.

PMID:
22252481
24.

Arginine cofactors on the polymerase ribozyme.

Yao C, Moretti JE, Struss PE, Spall JA, Müller UF.

PLoS One. 2011;6(9):e25030. doi: 10.1371/journal.pone.0025030. Epub 2011 Sep 20.

25.

The adaptor-associated kinase 1, AAK1, is a positive regulator of the Notch pathway.

Gupta-Rossi N, Ortica S, Meas-Yedid V, Heuss S, Moretti J, Olivo-Marin JC, Israël A.

J Biol Chem. 2011 May 27;286(21):18720-30. doi: 10.1074/jbc.M110.190769. Epub 2011 Apr 4.

26.

Medication errors in the homes of children with chronic conditions.

Walsh KE, Mazor KM, Stille CJ, Torres I, Wagner JL, Moretti J, Chysna K, Stine CD, Usmani GN, Gurwitz JH.

Arch Dis Child. 2011 Jun;96(6):581-6. doi: 10.1136/adc.2010.204479. Epub 2011 Mar 27.

PMID:
21444297
27.

Monte Carlo simulation of electron dose from (131)I-targeted tumor cells within a heterogeneous tumor.

Zanotti-Fregonara P, Champion C, Marzola MC, Rubello D, Just PA, Moretti JL, Hindié E.

Cancer Biother Radiopharm. 2011 Feb;26(1):135-40. doi: 10.1089/cbr.2010.0831.

PMID:
21355785
28.

The sentinel node procedure in breast cancer: nuclear medicine as the starting point.

Hindié E, Groheux D, Brenot-Rossi I, Rubello D, Moretti JL, Espié M.

J Nucl Med. 2011 Mar;52(3):405-14. doi: 10.2967/jnumed.110.081711. Epub 2011 Feb 14. Review.

29.

Nuclear Medicine in Early-Stage Melanoma: Sentinel Node Biopsy-FDG-PET/CT.

Hindié E, Sarandi F, Banayan S, Groheux D, Rubello D, Vercellino L, Toubert ME, Moretti JL, Lebbé C.

PET Clin. 2011 Jan;6(1):9-25. doi: 10.1016/j.cpet.2011.01.001. Epub 2011 Feb 23.

PMID:
27156352
30.

The translation initiation factor 3f (eIF3f) exhibits a deubiquitinase activity regulating Notch activation.

Moretti J, Chastagner P, Gastaldello S, Heuss SF, Dirac AM, Bernards R, Masucci MG, Israël A, Brou C.

PLoS Biol. 2010 Nov 23;8(11):e1000545. doi: 10.1371/journal.pbio.1000545.

31.

Early monitoring of response to neoadjuvant chemotherapy in breast cancer with 18F-FDG PET/CT: defining a clinical aim.

Groheux D, Giacchetti S, Espié M, Rubello D, Moretti JL, Hindié E.

Eur J Nucl Med Mol Imaging. 2011 Mar;38(3):419-25. doi: 10.1007/s00259-010-1660-5. No abstract available.

PMID:
21072510
32.

Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer.

Groheux D, Giacchetti S, Moretti JL, Porcher R, Espié M, Lehmann-Che J, de Roquancourt A, Hamy AS, Cuvier C, Vercellino L, Hindié E.

Eur J Nucl Med Mol Imaging. 2011 Mar;38(3):426-35. doi: 10.1007/s00259-010-1640-9. Epub 2010 Nov 6.

PMID:
21057787
33.

The evolving role of PET/CT in breast cancer.

Groheux D, Giacchetti S, Rubello D, Al-Nahhas A, Moretti JL, Espié M, Hindié E.

Nucl Med Commun. 2010 Apr;31(4):271-3. doi: 10.1097/MNM.0b013e3283354cb4. No abstract available.

PMID:
20375973
34.

(18)F-FDG PET/CT bone/bone marrow findings in Hodgkin's lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging.

Moulin-Romsee G, Hindié E, Cuenca X, Brice P, Decaudin D, Bénamor M, Brière J, Anitei M, Filmont JE, Sibon D, de Kerviler E, Moretti JL.

Eur J Nucl Med Mol Imaging. 2010 Jun;37(6):1095-105. doi: 10.1007/s00259-009-1377-5. Epub 2010 Mar 4.

PMID:
20204358
35.

[PET-CT for evaluation of the solitary pulmonary nodule: an update].

Groheux D, Hindié E, Trédaniel J, Giraudet AL, Vaylet F, Berenger N, Moretti JL.

Rev Mal Respir. 2009 Dec;26(10):1041-55. Review. French.

PMID:
20032840
36.

Parathyroid scintigraphy findings in chronic kidney disease patients with recurrent hyperparathyroidism.

Hindié E, Zanotti-Fregonara P, Just PA, Sarfati E, Mellière D, Toubert ME, Moretti JL, Jeanguillaume C, Keller I, Ureña-Torres P.

Eur J Nucl Med Mol Imaging. 2010 Mar;37(3):623-34. doi: 10.1007/s00259-009-1313-8. Epub 2009 Nov 28.

PMID:
19946686
37.

[PET/CT in breast cancer: an update].

Groheux D, Moretti JL, Giacchetti S, Hindié E, Teyton P, Cuvier C, Bousquet G, Misset JL, Boin C, Espié M.

Bull Cancer. 2009 Nov;96(11):1053-70. doi: 10.1684/bdc.2009.0950. Review. French.

38.

Effect of variation in relaxation parameter value on LOR-RAMLA reconstruction of 18F-FDG PET studies.

Groheux D, Martineau A, Vrigneaud JM, Hindie E, Baillet G, Moretti JL.

Nucl Med Commun. 2009 Dec;30(12):926-33. doi: 10.1097/MNM.0b013e32832ed3cf.

PMID:
19574939
39.

Hepatosplenic candidiasis imaged with F-18 FDG PET/CT.

Teyton P, Baillet G, Hindié E, Filmont JE, Sarandi F, Toubert ME, Moretti JL.

Clin Nucl Med. 2009 Jul;34(7):439-40. doi: 10.1097/RLU.0b013e3181a7cfba. No abstract available.

PMID:
19542950
40.

Enhanced responses to ganglion blockade do not reflect sympathetic nervous system contribution to angiotensin II-induced hypertension.

Moretti JL, Burke SL, Evans RG, Lambert GW, Head GA.

J Hypertens. 2009 Sep;27(9):1838-48. doi: 10.1097/HJH.0b013e32832dd0d8.

PMID:
19512943
41.

[Sentinel node biopsy in breast cancer].

Hindié E, Groheux D, Espie M, Bourstyn E, Toubert ME, Sarandi F, de Roquancourt A, Giacchetti S, Cuvier C, Cahen-Doidy L, Teyton P, Misset JL, Maylin C, Moretti JL.

Bull Cancer. 2009 Jun;96(6):713-25. doi: 10.1684/bdc.2009.0879. French.

42.

Should FDG PET/CT be used for the initial staging of breast cancer?

Groheux D, Hindié E, Rubello D, Espié M, Baillet G, Giacchetti S, Misset JL, Moretti JL.

Eur J Nucl Med Mol Imaging. 2009 Oct;36(10):1539-42. doi: 10.1007/s00259-009-1159-0. Review. No abstract available.

PMID:
19449002
43.

Reply to: Determinants of (131)I radiation dose to thyroid follicular cells.

Hindié E, Champion C, Zanotti-Fregonara P, Rubello D, Moretti JL.

Eur J Nucl Med Mol Imaging. 2009 Jun;36(6):1015-6. doi: 10.1007/s00259-009-1144-7. No abstract available.

PMID:
19399498
44.

[Advantages of PET-CT in the work-up of cervical cancer].

Groheux D, Hindie E, Baillet G, Hennequin C, Misset JL, Sarandi F, Toubert ME, Barre E, Moretti JL.

Bull Cancer. 2009 Feb;96(2):199-211. doi: 10.1684/bdc.2008.0815. Review. French.

45.

18F-FDG PET/CT imaging for an early assessment of response to sunitinib in metastatic renal carcinoma: preliminary study.

Vercellino L, Bousquet G, Baillet G, Barré E, Mathieu O, Just PA, Desgrandchamps F, Misset JL, Hindié E, Moretti JL.

Cancer Biother Radiopharm. 2009 Feb;24(1):137-44. doi: 10.1089/cbr.2008.0527.

PMID:
19243256
46.

[Benign schwannoma with high uptake of 18 fluorodeoxglucose (PET-Scan)].

Sadok Boudaya M, Dechaud C, Gossot D, Validire P, Magdeleinat P, Moretti JL.

Rev Mal Respir. 2009 Jan;26(1):63-5. French.

PMID:
19212292
47.

[Use of fluorine-18-FDG PET-CT scans in initial management and follow-up of patients with cutaneous melanoma].

Sarandi F, Hindié E, Kerob D, Basset-Seguin N, Lebbé C, Toubert ME, Filmont JE, Groheux D, Teyton P, Moretti JL.

Ann Dermatol Venereol. 2008 Oct;135(10):691-9. doi: 10.1016/j.annder.2008.05.011. Epub 2008 Jul 31. French. No abstract available.

PMID:
18929924
48.

Update on the diagnosis and therapy of distant metastases of differentiated thyroid carcinoma.

Zanotti-Fregonara P, Hindié E, Faugeron I, Moretti JL, Ravasi L, Rubello D, Toubert ME.

Minerva Endocrinol. 2008 Dec;33(4):313-27. Review.

PMID:
18923368
49.

18F-fluorodeoxyglucose positron emission tomography/computed tomography in AIDS-related Burkitt lymphoma.

Just PA, Fieschi C, Baillet G, Galicier L, Oksenhendler E, Moretti JL.

AIDS Patient Care STDS. 2008 Sep;22(9):695-700. doi: 10.1089/apc.2008.0174.

PMID:
18793085
50.

Slow dynamic lymphoscintigraphy is not a reliable predictor of sentinel-node negativity in cutaneous melanoma.

Toubert ME, Just PA, Baillet G, Kerob D, Hindié E, Verola O, Revol M, Servant JM, Basset-Seguin N, Lebbé C, Banti E, Rubello D, Moretti JL.

Cancer Biother Radiopharm. 2008 Aug;23(4):443-50. doi: 10.1089/cbr.2008.0468.

PMID:
18771348

Supplemental Content

Loading ...
Support Center